867
Clinicians who manage cachectic patients, particularly those with protracted diarrhoea and/or receiving anti-malarial drugs including mefloquine, should be aware of the risk of severe hypoglycaemia.
 ( adverse event: risk ,  cachectic patients: Subject, with protracted diarrhoea: Subject, severe hypoglycaemia: Effect, anti-malarial drugs including mefloquine: Treatment, mefloquine: Treatment.Drug, cachectic: Treatment.Disorder, protracted diarrhoea: Treatment.Disorder) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: risk ,  cachectic patients: Subject, with protracted diarrhoea: Subject, severe hypoglycaemia: Effect, anti-malarial drugs including mefloquine: Treatment, mefloquine: Treatment.Drug, cachectic: Treatment.Disorder, protracted diarrhoea: Treatment.Disorder) 